Diabetes, Vol 40, Issue 7 939-942, Copyright © 1991 by American Diabetes Association

ARTICLES

Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans

MC McGuire, RM Fields, BL Nyomba, I Raz, C Bogardus, NK Tonks and J Sommercorn
Clinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona 85016.

Insulin resistance in skeletal muscle may be an expression of the genetic basis of a common form of non-insulin-dependent diabetes mellitus (NIDDM) in humans. Impaired insulin action results from an apparent postreceptor defect in insulin signal transduction that limits the influence of the hormone on various protein serine/threonine kinases and phosphatases that are thought to contribute to the mechanism by which insulin affects intracellular events. The fact that numerous responses to insulin are affected suggests that the cause of insulin resistance involves an early step in insulin action. Therefore, we examined the influence of insulin on protein tyrosine phosphatase (PTPase) activities, which may counteract the protein tyrosine kinase activity of the insulin receptor in skeletal muscle of insulin-sensitive and insulin-resistant humans. Insulin infusion in vivo produced a rapid 25% suppression of soluble-PTPase activity in muscle of insulin-sensitive subjects, but this response was severely impaired in subjects who were insulin resistant. Insulin did not affect PTPase activity in the particulate fraction of muscle from either group, but basal particulate activity was 33% higher in resistant subjects than in sensitive subjects. Either or both of these abnormal characteristics of PTPase activities could be central to the causes of insulin resistance and NIDDM.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Meshkani, M. Taghikhani, H. Al-Kateb, B. Larijani, S. Khatami, G. K. Sidiropoulos, R. A. Hegele, and K. Adeli Polymorphisms within the Protein Tyrosine Phosphatase 1B (PTPN1) Gene Promoter: Functional Characterization and Association with Type 2 Diabetes and Related Metabolic Traits Clin. Chem., September 1, 2007; 53(9): 1585 - 1592. [Abstract] [Full Text] [PDF]

				N. T. Lam, J. T. Lewis, A. T. Cheung, C. T. Luk, J. Tse, J. Wang, M. Bryer-Ash, J. K. Kolls, and T. J. Kieffer Leptin Increases Hepatic Insulin Sensitivity and Protein Tyrosine Phosphatase 1B Expression Mol. Endocrinol., June 1, 2004; 18(6): 1333 - 1345. [Abstract] [Full Text] [PDF]

				J. Weng, J. Yan, Z. Huang, Y. Sui, and L. Xiu Missense Mutation of Pro387Leu in Protein Tyrosine Phosphatase-1B (PTP-1B) Is Not Associated With Type 2 Diabetes in a Chinese Han Population Diabetes Care, October 1, 2003; 26(10): 2957 - 2957. [Full Text] [PDF]

				T. M. Frimurer, G. H. Peters, L. F. Iversen, H. S. Andersen, N. P. H. Moller, and O. H. Olsen Ligand-Induced Conformational Changes: Improved Predictions of Ligand Binding Conformations and Affinities Biophys. J., April 1, 2003; 84(4): 2273 - 2281. [Abstract] [Full Text] [PDF]

				C. M. Rondinone, J. M. Trevillyan, J. Clampit, R. J. Gum, C. Berg, P. Kroeger, L. Frost, B. A. Zinker, R. Reilly, R. Ulrich, et al. Protein Tyrosine Phosphatase 1B Reduction Regulates Adiposity and Expression of Genes Involved in Lipogenesis Diabetes, August 1, 2002; 51(8): 2405 - 2411. [Abstract] [Full Text] [PDF]

				B. J. Goldstein Protein-Tyrosine Phosphatases: Emerging Targets for Therapeutic Intervention in Type 2 Diabetes and Related States of Insulin Resistance J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2474 - 2480. [Full Text] [PDF]

				P. Vollenweider, B. Menard, and P. Nicod Insulin Resistance, Defective Insulin Receptor Substrate 2--Associated Phosphatidylinositol-3' Kinase Activation, and Impaired Atypical Protein Kinase C ({zeta}/{lambda}) Activation in Myotubes From Obese Patients With Impaired Glucose Tolerance Diabetes, April 1, 2002; 51(4): 1052 - 1059. [Abstract] [Full Text] [PDF]

				C. Taghibiglou, F. Rashid-Kolvear, S. C. Van Iderstine, H. Le-Tien, I. G. Fantus, G. F. Lewis, and K. Adeli Hepatic Very Low Density Lipoprotein-ApoB Overproduction Is Associated with Attenuated Hepatic Insulin Signaling and Overexpression of Protein-tyrosine Phosphatase 1B in a Fructose-fed Hamster Model of Insulin Resistance J. Biol. Chem., January 4, 2002; 277(1): 793 - 803. [Abstract] [Full Text]

				S. M. Echwald, H. Bach, H. Vestergaard, B. Richelsen, K. Kristensen, T. Drivsholm, K. Borch-Johnsen, T. Hansen, and O. Pedersen A P387L Variant in Protein Tyrosine Phosphatase-1B (PTP-1B) Is Associated With Type 2 Diabetes and Impaired Serine Phosphorylation of PTP-1B In Vitro Diabetes, January 1, 2002; 51(1): 1 - 6. [Abstract] [Full Text] [PDF]

				S. Tang, H. Le-Tien, B. J. Goldstein, P. Shin, R. Lai, and I. G. Fantus Decreased In Situ Insulin Receptor Dephosphorylation in Hyperglycemia-Induced Insulin Resistance in Rat Adipocytes Diabetes, January 1, 2001; 50(1): 83 - 90. [Abstract] [Full Text]

				L. D. Klaman, O. Boss, O. D. Peroni, J. K. Kim, J. L. Martino, J. M. Zabolotny, N. Moghal, M. Lubkin, Y.-B. Kim, A. H. Sharpe, et al. Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice Mol. Cell. Biol., August 1, 2000; 20(15): 5479 - 5489. [Abstract] [Full Text]

				H. K. Kole, M. J. Garant, S. Kole, and M. Bernier A Peptide-based Protein-tyrosine Phosphatase Inhibitor Specifically Enhances Insulin Receptor Function in Intact Cells J. Biol. Chem., June 14, 1996; 271(24): 14302 - 14307. [Abstract] [Full Text] [PDF]

				H. Maegawa, R. Ide, M. Hasegawa, S. Ugi, K. Egawa, M. Iwanishi, R. Kikkawa, Y. Shigeta, and A. Kashiwagi Thiazolidine Derivatives Ameliorate High Glucose-induced Insulin Resistance via the Normalization of Protein-tyrosine Phosphatase Activities J. Biol. Chem., March 31, 1995; 270(13): 7724 - 7730. [Abstract] [Full Text] [PDF]

				N.K. Tonks, Q. Yang, A.J. Flint, M.F.B.G. Gebbink, B.R. Franza Jr., D.E. Hill, H. Sun, and S. Brady-Kalnay Protein Tyrosine Phosphatases: The Problems of a Growing Family Cold Spring Harb Symp Quant Biol, January 1, 1992; 57(0): 87 - 94. [Abstract] [PDF]

				K. Egawa, H. Maegawa, S. Shimizu, K. Morino, Y. Nishio, M. Bryer-Ash, A. T. Cheung, J. K. Kolls, R. Kikkawa, and A. Kashiwagi Protein-tyrosine Phosphatase-1B Negatively Regulates Insulin Signaling in L6 Myocytes and Fao Hepatoma Cells J. Biol. Chem., March 23, 2001; 276(13): 10207 - 10211. [Abstract] [Full Text] [PDF]

				C. L. Venable, E. U. Frevert, Y.-B. Kim, B. M. Fischer, S. Kamatkar, B. G. Neel, and B. B. Kahn Overexpression of Protein-tyrosine Phosphatase-1B in Adipocytes Inhibits Insulin-stimulated Phosphoinositide 3-Kinase Activity without Altering Glucose Transport or Akt/Protein Kinase B Activation J. Biol. Chem., June 9, 2000; 275(24): 18318 - 18326. [Abstract] [Full Text] [PDF]

				J. M. Zabolotny, Y.-B. Kim, O. D. Peroni, J. K. Kim, M. A. Pani, O. Boss, L. D. Klaman, S. Kamatkar, G. I. Shulman, B. B. Kahn, et al. Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance PNAS, April 24, 2001; 98(9): 5187 - 5192. [Abstract] [Full Text] [PDF]